Ross S. Berkowitz, MD

Ross S. Berkowitz, MD

Surgical Oncology

Contact Information

Office Phone Number

617-732-8840

Fax

617-394-2633

Appointments

617-632-2175 (new)

Biography

Ross S. Berkowitz, MD

Dr. Berkowitz received his MD from Boston University in 1973 and completed residency training in surgery at the Peter Bent Brigham Hospital. He trained in obstetrics and gynecology at the Boston Hospital for Women, where he completed a fellowship in gynecologic oncology. He joined the faculty of Brigham and Women's Hospital in 1980, and is the director of the Division of Gynecologic Oncology at Dana-Farber/Partners CancerCare.

Researcher

Physician

Surgical Director, Gynecologic Oncology
William H. Baker Professor of Gynecology, Harvard Medical School

Centers/Programs

Clinical Interests

Abnormal pap smears, Gynecologic oncology, Ovarian tumors, Pelvic tumors, Trophoblastic disease, Uterine tumors

Board Certification

  • Gynecologic Oncology, 1982
  • Obstetrics & Gynecology, 1981

Fellowship

  • Boston Hospital for Women, Gynecologic Oncology

Residency

  • Boston Hospital for Women, Obstetrics & Gynecology
  • Peter Bent Brigham Hospital/Harvard Medical School, Surgery

Medical School

  • Boston University School of Medicine

Recent Awards

  • Honorary Member, Hungarian National Academy of Science 1999

Research

    Gestational Trophoblastic Disease and Ovarian Carcinogenesis

    Working closely with Dr. Donald P. Goldstein and Marilyn Bernstein, MHP, we are studying the natural history, epidemiology, treatment, and molecular biology of gestational trophoblastic disease. In collaboration with Drs. Shu-Wing Ng, Michael Muto, and Daniel Cramer, we are also pursuing studies of the genetic changes in invasive epithelial ovarian cancer, borderline ovarian tumors, and peritoneal malignancy. The Gynecologic Oncology Laboratory focuses on determining the early genetic changes in the development of ovarian cancer. Using DNA microarray technology, we have identified several promising markers including prostasin and osteopontin, which are elevated in the serum of patients with early ovarian cancer and significantly improve the sensitivity and specitivity of CA125 in the detection of ovarian cancer. Important advances have also been made in the understanding of the early genetic changes in ovarian cancer. Mucinous ovarian cancer is often associated with benign and borderline malignant mucinous epithelium in the same tissue. The same K-ras mutation has been demonstrated in adjacent benign, borderline malignant, and malignant mucinous epithelium in tissues precisely isolated by laser capture microscopy. K-ras mutation may be an early event in mucinous ovarian tumorigenesis, and benign and borderline mucinous epithelium may be a precursor of mucinous carcinoma. Patients with borderline serous ovarian cancer may later develop invasive serous ovarian cancer. By studying p53 and K-ras mutations, we have found that serous borderline ovarian tumor and subsequent invasive serous carcinomas seem to be unrelated. Patients with BRCA1 or BRCA2 mutations have a 20% to 40% risk of developing ovarian cancer and, therefore, prophylactic oophorectomy has been advocated as a preventive strategy. Importantly, papillary serous peritoneal cancer may also develop in patients with BRA1 and BRA2 mutations, and ovaries removed prophylactically may already harbor occult ovarian malignancy. Placental site trophoblastic tumor (PSTT) is an unusual variant that is relatively resistant to chemotherapy. Based on our clinical experience, patients with nonmetastatic PSTT should undergo hysterectomy as primary therapy. Patients with gestational trophoblastic tumors are commonly cured with chemotherapy while preserving their fertility. Data from more than 500 patients who became pregnant following chemotherapy indicate that the outcome from these pregnancies is about the same as the general population.

    Publications

      • Geographical Health District and Distance Traveled Influence on Clinical Status at Admission of Patients with Gestational Trophoblastic Disease. Rev Bras Ginecol Obstet. 2023 Jul; 45(7):e384-e392. View in: Pubmed

      • Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases. Clinics (Sao Paulo). 2023; 78:100260. View in: Pubmed

      • The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women. Gynecol Oncol. 2023 09; 176:130-138. View in: Pubmed

      • Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review. Gynecol Oncol. 2023 03; 170:179-185. View in: Pubmed

      • EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study. Gynecol Oncol. 2023 03; 170:114-122. View in: Pubmed

      • Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia. PLoS One. 2022; 17(12):e0277892. View in: Pubmed

      • Current chemotherapeutic options for the treatment of gestational trophoblastic disease. Expert Opin Pharmacother. 2023 Feb; 24(2):245-258. View in: Pubmed

      • Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational study. BJOG. 2022 Oct 09. View in: Pubmed

      • Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia. Rev Bras Ginecol Obstet. 2022 Aug; 44(8):746-754. View in: Pubmed

      • Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene. 2022 Jun; 41(26):3510. View in: Pubmed

      • A természetes ölosejtek szerepe az anyai-magzati immunhomeostasis fenntartásában. Orv Hetil. 2022 May 08; 163(19):734-742. View in: Pubmed

      • ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene. 2022 04; 41(18):2540-2554. View in: Pubmed

      • Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol. BMJ Open. 2022 Feb 24; 12(2):e059484. View in: Pubmed

      • Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism. Gynecol Oncol. 2022 04; 165(1):137-142. View in: Pubmed

      • Isolation and culture of decidual natural killer cells from term placenta and complete hydatidiform mole. J Reprod Immunol. 2022 03; 150:103475. View in: Pubmed

      • Perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia: a systematic review of observational studies and meta-analysis. Am J Obstet Gynecol. 2022 05; 226(5):633-645.e8. View in: Pubmed

      • A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease. Lancet Oncol. 2021 11; 22(11):1490-1491. View in: Pubmed

      • Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021 Oct; 155 Suppl 1:86-93. View in: Pubmed

      • Gestational trophoblastic neoplasia: one size does not fit all - Authors' reply. Lancet Oncol. 2021 10; 22(10):e421. View in: Pubmed

      • Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery. Int J Gynecol Cancer. 2021 10; 31(10):1356-1362. View in: Pubmed

      • Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia. Rev Bras Ginecol Obstet. 2021 Jul; 43(7):503-506. View in: Pubmed

      • Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy. Clinics (Sao Paulo). 2021; 76:e2830. View in: Pubmed

      • Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer. Int J Gynecol Cancer. 2021 10; 31(10):1341-1347. View in: Pubmed

      • Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right? Gynecol Oncol. 2021 09; 162(3):638-644. View in: Pubmed

      • Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes. Cancers (Basel). 2021 Jun 28; 13(13). View in: Pubmed

      • Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study. Lancet Oncol. 2021 08; 22(8):1188-1198. View in: Pubmed

      • Loss of Selenoprotein Iodothyronine Deiodinase 3 Expression Correlates with Progression of Complete Hydatidiform Mole to Gestational Trophoblastic Neoplasia. Reprod Sci. 2021 11; 28(11):3200-3211. View in: Pubmed

      • Treatment of hydatidiform mole using manual vacuum aspiration: technical and tactical aspects. Int J Gynecol Cancer. 2021 09; 31(9):1299-1300. View in: Pubmed

      • Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions. Cancers (Basel). 2021 May 03; 13(9). View in: Pubmed

      • Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer. Ann Surg Oncol. 2021 Oct; 28(11):6705-6713. View in: Pubmed

      • Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples. Am J Reprod Immunol. 2021 07; 86(1):e13394. View in: Pubmed

      • Video Hysteroscopy in the Diagnosis of Molar Pregnancy in two Challenging Situations: Complete Mole with Normal hCG and Partial Mole with Early Gestational Age. J Minim Invasive Gynecol. 2021 08; 28(8):1448-1449. View in: Pubmed

      • Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease. Best Pract Res Clin Obstet Gynaecol. 2021 Jul; 74:81-96. View in: Pubmed

      • When less is more: regarding the use of chest X-ray instead of computed tomography in screening for pulmonary metastasis in postmolar gestational trophoblastic neoplasia. Br J Cancer. 2021 03; 124(6):1033-1034. View in: Pubmed

      • Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer. Sci Rep. 2020 11 18; 10(1):20071. View in: Pubmed

      • Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Res. 2021 01 01; 81(1):158-173. View in: Pubmed

      • Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression. Am J Obstet Gynecol. 2021 04; 224(4):372.e1-372.e30. View in: Pubmed

      • Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy. Gynecol Oncol. 2020 12; 159(3):751-757. View in: Pubmed

      • Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study. Curr Probl Cancer. 2021 02; 45(1):100622. View in: Pubmed

      • Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole. Clinics (Sao Paulo). 2020; 75:e1724. View in: Pubmed

      • Differential blood count as triage tool in evaluation of pelvic masses. Int J Gynecol Cancer. 2021 05; 31(5):733-743. View in: Pubmed

      • Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer. Int J Gynecol Cancer. 2020 07; 30(7):1052-1057. View in: Pubmed

      • How to optimize the management of gestational trophoblastic disease during the coronavirus disease era? Am J Obstet Gynecol. 2020 10; 223(4):604-605. View in: Pubmed

      • EMA vs EMACO in the treatment of gestational trophoblastic neoplasia. Gynecol Oncol. 2020 07; 158(1):99-104. View in: Pubmed

      • Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study. Gynecol Oncol. 2020 08; 158(2):452-459. View in: Pubmed

      • Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America. Int J Gynecol Cancer. 2020 09; 30(9):1366-1371. View in: Pubmed

      • Important insights for non-molar choriocarcinoma. BJOG. 2020 08; 127(9):1108. View in: Pubmed

      • MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread. Oncogene. 2020 05; 39(20):4045-4060. View in: Pubmed

      • Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2020 05; 157(2):372-378. View in: Pubmed

      • Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend. Gynecol Oncol. 2020 03; 156(3):598-605. View in: Pubmed

      • Considering Changes in the Recommended Human Chorionic Gonadotropin Monitoring After Molar Evacuation. Obstet Gynecol. 2020 01; 135(1):9-11. View in: Pubmed

      • State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia. J Natl Compr Canc Netw. 2019 11 01; 17(11):1396-1401. View in: Pubmed

      • Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough? Gynecol Oncol. 2019 10; 155(1):1-2. View in: Pubmed

      • A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Am J Obstet Gynecol. 2019 10; 221(4):326.e1-326.e7. View in: Pubmed

      • Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240. View in: Pubmed

      • Liquid biopsy of HPV DNA in cervical cancer. J Clin Virol. 2019 05; 114:32-36. View in: Pubmed

      • Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia? Gynecol Oncol. 2019 05; 153(2):277-285. View in: Pubmed

      • Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma. Int J Gynecol Cancer. 2019 03; 29(3):585-592. View in: Pubmed

      • Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter? Gynecol Oncol. 2019 04; 153(1):63-67. View in: Pubmed

      • Targeted Next-Generation Sequencing Reveals Clinically Actionable BRAF and ESR1 Mutations in Low-Grade Serous Ovarian Carcinoma. JCO Precis Oncol. 2018; 2018. View in: Pubmed

      • Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018 Oct; 143 Suppl 2:79-85. View in: Pubmed

      • Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas. J Pathol. 2018 11; 246(3):344-351. View in: Pubmed

      • Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study. J Med Internet Res. 2018 09 24; 20(9):e10897. View in: Pubmed

      • Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids. Cancer Discov. 2018 11; 8(11):1404-1421. View in: Pubmed

      • In Reply. Obstet Gynecol. 2018 07; 132(1):218. View in: Pubmed

      • Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery? Gynecol Oncol. 2018 08; 150(2):233-238. View in: Pubmed

      • The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts. Gynecol Oncol. 2018 07; 150(1):67-72. View in: Pubmed

      • Gestational Trophoblastic Disease Electronic Consults: What Do Patients and Physicians Want to Know? Int J Gynecol Cancer. 2018 05; 28(4):824-828. View in: Pubmed

      • De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary. Int J Gynecol Pathol. 2018 May; 37(3):296-300. View in: Pubmed

      • Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy. Obstet Gynecol. 2018 04; 131(4):652-659. View in: Pubmed

      • Meigs to modern times: The evolution of debulking surgery in advanced ovarian cancer. Gynecol Oncol. 2018 06; 149(3):447-454. View in: Pubmed

      • Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers. J Ovarian Res. 2018 Mar 02; 11(1):20. View in: Pubmed

      • Extramammary Paget Disease of the Vulva: A Case Series Examining Treatment, Recurrence, and Malignant Transformation. Int J Gynecol Cancer. 2018 03; 28(3):632-638. View in: Pubmed

      • Does a human chorionic gonadotropin level of over 20,000?IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia? Eur J Obstet Gynecol Reprod Biol. 2018 Apr; 223:50-55. View in: Pubmed

      • Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma? Gynecol Oncol. 2018 02; 148(2):239-246. View in: Pubmed

      • Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute. Gynecol Oncol. 2018 01; 148(1):5-11. View in: Pubmed

      • Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife. 2017 10 31; 6. View in: Pubmed

      • Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience. Gynecol Oncol. 2018 01; 148(1):161-167. View in: Pubmed

      • Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors? Gynecol Oncol. 2017 11; 147(2):364-370. View in: Pubmed

      • Heterotopic Pregnancy Including Intrauterine Normal Gestation and Tubal Complete Hydatidiform Mole: A Case Report and Review of the Literature. Int J Gynecol Pathol. 2017 Sep; 36(5):428-432. View in: Pubmed

      • Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. BMC Cancer. 2017 Jun 17; 17(1):422. View in: Pubmed

      • Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women. Gynecol Oncol. 2017 08; 146(2):334-339. View in: Pubmed

      • Type I interferons modulate methotrexate resistance in gestational trophoblastic neoplasia. Am J Reprod Immunol. 2017 06; 77(6). View in: Pubmed

      • Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol. 2017 Mar; 36(2):115-127. View in: Pubmed

      • Correction: Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells. Oncotarget. 2017 02 14; 8(7):12533. View in: Pubmed

      • Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review. Gynecol Oncol. 2017 Apr; 145(1):88-95. View in: Pubmed

      • Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation? Gynecol Oncol. 2016 Dec; 143(3):558-564. View in: Pubmed

      • Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA. Mod Pathol. 2017 03; 30(3):448-458. View in: Pubmed

      • Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities. Gynecol Oncol. 2017 Jan; 144(1):208-214. View in: Pubmed

      • Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma. Oncotarget. 2016 Oct 04; 7(40):66077-66086. View in: Pubmed

      • Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells. Eur J Cancer. 2016 11; 67:152-163. View in: Pubmed

      • Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia. Gynecol Oncol. 2016 09; 142(3):496-500. View in: Pubmed

      • Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol. 2016 10; 143(1):73-76. View in: Pubmed

      • Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer. Int J Gynecol Cancer. 2016 07; 26(6):1033-40. View in: Pubmed

      • Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery? Gynecol Oncol. 2016 08; 142(2):255-60. View in: Pubmed

      • Changing Trends in the Clinical Presentation and Management of Complete Hydatidiform Mole Among Brazilian Women. Int J Gynecol Cancer. 2016 06; 26(5):984-90. View in: Pubmed

      • Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas. Mod Pathol. 2016 08; 29(8):893-903. View in: Pubmed

      • Timing of Referral to the New England Trophoblastic Disease Center: Does Referral with Molar Pregnancy Versus Postmolar Gestational Trophoblastic Neoplasia Affect Outcomes? J Reprod Med. 2016 May-Jun; 61(5-6):187-91. View in: Pubmed

      • Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013. J Reprod Med. 2016 May-Jun; 61(5-6):210-4. View in: Pubmed

      • Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries. J Reprod Med. 2016 May-Jun; 61(5-6):224-9. View in: Pubmed

      • The Role of Surgery in the Management of Gestational Trophoblastic Neoplasia The Hungarian Experience. J Reprod Med. 2016 May-Jun; 61(5-6):197-204. View in: Pubmed

      • Gestational Trophoblastic Disease: Presentations from the XVIIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2016 May-Jun; 61(5-6):185-6. View in: Pubmed

      • Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center. Am J Obstet Gynecol. 2016 09; 215(3):334.e1-6. View in: Pubmed

      • Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2016 09; 215(3):336.e1-336.e12. View in: Pubmed

      • Gestational Trophoblastic Neoplasia Treatment at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2016 Dec; 2(6):365-374. View in: Pubmed

      • Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells. Oncotarget. 2016 Mar 08; 7(10):11397-411. View in: Pubmed

      • Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades. Int J Gynecol Cancer. 2016 Feb; 26(2):367-70. View in: Pubmed

      • Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells. Oncotarget. 2016 Jan 26; 7(4):4110-21. View in: Pubmed

      • The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. Gynecol Oncol. 2016 Mar; 140(3):470-3. View in: Pubmed

      • Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1606-7. View in: Pubmed

      • Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1611. View in: Pubmed

      • Optimal management of low-risk gestational trophoblastic neoplasia. Expert Rev Anticancer Ther. 2015; 15(11):1293-304. View in: Pubmed

      • Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2015 Oct; 131 Suppl 2:S123-6. View in: Pubmed

      • Molecular changes in endometriosis-associated ovarian clear cell carcinoma. Eur J Cancer. 2015 Sep; 51(13):1831-42. View in: Pubmed

      • Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol. 2015 Jul; 138(1):46-9. View in: Pubmed

      • Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer. Ann Surg Oncol. 2016 Jan; 23(1):178-85. View in: Pubmed

      • Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2015 May; 25(4):734-40. View in: Pubmed

      • Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2015 Jul; 138(1):50-4. View in: Pubmed

      • Vaginal brachytherapy for early-stage carcinosarcoma of the uterus. Brachytherapy. 2015 Jul-Aug; 14(4):433-9. View in: Pubmed

      • Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell. 2015 Feb 26; 160(5):977-989. View in: Pubmed

      • Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. Int J Cancer. 2015 Aug 15; 137(4):776-83. View in: Pubmed

      • Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? Gynecol Oncol. 2015 Apr; 137(1):60-5. View in: Pubmed

      • Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet. 2015 Jan; 37(1):42-51. View in: Pubmed

      • Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015 Apr; 22(4):1341-8. View in: Pubmed

      • Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma. Gynecol Oncol. 2014 Oct; 135(1):54-7. View in: Pubmed

      • Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2014 Jun; 24(5):941-5. View in: Pubmed

      • Gestational trophoblastic disease: presentations from the XVIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2014 May-Jun; 59(5-6):187. View in: Pubmed

      • Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. J Reprod Med. 2014 May-Jun; 59(5-6):188-94. View in: Pubmed

      • Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary. J Reprod Med. 2014 May-Jun; 59(5-6):227-34. View in: Pubmed

      • What is the optimal treatment for obese patients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014 Sep; 211(3):231.e1-9. View in: Pubmed

      • Protein kinases and associated pathways in pluripotent state and lineage differentiation. Curr Stem Cell Res Ther. 2014; 9(5):366-87. View in: Pubmed

      • Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens. Gynecol Oncol. 2014 Feb; 132(2):316-21. View in: Pubmed

      • Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol. 2014 Feb; 132(2):280-6. View in: Pubmed

      • Knockdown of core binding factorß alters sphingolipid metabolism. J Cell Physiol. 2013 Dec; 228(12):2350-64. View in: Pubmed

      • Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes. PLoS One. 2013; 8(11):e80314. View in: Pubmed

      • Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen. Gynecol Oncol. 2014 Jan; 132(1):65-9. View in: Pubmed

      • A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer. Gynecol Oncol. 2014 Jan; 132(1):55-60. View in: Pubmed

      • p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases. Gynecol Oncol. 2013 Dec; 131(3):759-63. View in: Pubmed

      • Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer. Gynecol Oncol. 2013 Oct; 131(1):69-76. View in: Pubmed

      • Changes in clinical presentation of postterm choriocarcinoma at the New England Trophoblastic Disease Center in recent years. Gynecol Oncol. 2013 Sep; 130(3):483-6. View in: Pubmed

      • Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol. 2013 Sep; 130(3):545-9. View in: Pubmed

      • BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2. Neoplasia. 2013 Jun; 15(6):600-8. View in: Pubmed

      • Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6. View in: Pubmed

      • Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2013 Aug; 130(2):312-6. View in: Pubmed

      • Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci. 2013 Mar 06; 14(3):5367-79. View in: Pubmed

      • Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery? Gynecol Oncol. 2013 Apr; 129(1):69-73. View in: Pubmed

      • Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013 Apr; 129(1):63-8. View in: Pubmed

      • Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer. Gynecol Oncol. 2013 Apr; 129(1):18-21. View in: Pubmed

      • Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):E2939-48. View in: Pubmed

      • Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res. 2012 Oct 15; 18(20):5806-15. View in: Pubmed

      • Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle. 2012 Aug 01; 11(15):2876-84. View in: Pubmed

      • Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures. BMC Cancer. 2012 Aug 01; 12:329. View in: Pubmed

      • Current advances in the management of gestational trophoblastic disease. Gynecol Oncol. 2013 Jan; 128(1):3-5. View in: Pubmed

      • Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study. J Reprod Med. 2012 Jul-Aug; 57(7-8):305-9. View in: Pubmed

      • Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years. J Reprod Med. 2012 Jul-Aug; 57(7-8):310-8. View in: Pubmed

      • Casein kinase I epsilon interacts with mitochondrial proteins for the growth and survival of human ovarian cancer cells. EMBO Mol Med. 2012 Sep; 4(9):952-63. View in: Pubmed

      • Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta. J Reprod Med. 2012 May-Jun; 57(5-6):197-203. View in: Pubmed

      • Gestational trophoblastic neoplasia in adolescents. J Reprod Med. 2012 May-Jun; 57(5-6):237-42. View in: Pubmed

      • Complete hydatidiform mole in women aged 40 to 49 years. J Reprod Med. 2012 May-Jun; 57(5-6):254-8. View in: Pubmed

      • Molar pregnancy in adolescents. J Reprod Med. 2012 May-Jun; 57(5-6):225-30. View in: Pubmed

      • Gestational trophoblastic disease: Presentations from the XVIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2012 May-Jun; 57(5-6):187-8. View in: Pubmed

      • A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia. J Reprod Med. 2012 May-Jun; 57(5-6):211-8. View in: Pubmed

      • Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol. 2012 May; 125(2):376-80. View in: Pubmed

      • Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2012 May; 125(2):362-6. View in: Pubmed

      • Gynecologic cancer. Hematol Oncol Clin North Am. 2012 Feb; 26(1):xi-xii. View in: Pubmed

      • Direct identification of an HPV-16 tumor antigen from cervical cancer biopsy specimens. Front Immunol. 2011; 2:75. View in: Pubmed

      • Current management of gestational trophoblastic neoplasia. Hematol Oncol Clin North Am. 2012 Feb; 26(1):111-31. View in: Pubmed

      • The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol Oncol. 2011 Dec; 123(3):542-7. View in: Pubmed

      • Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract. 2011; 2011:806256. View in: Pubmed

      • Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 2011 Jul; 122(1):178-82. View in: Pubmed

      • Cerebral venous sinus thrombosis presenting as cerebral metastasis in a patient with choriocarcinoma following a non-molar gestation. Gynecol Oncol. 2011 Jul; 122(1):199-200. View in: Pubmed

      • Differential hRad17 expression by histologic subtype of ovarian cancer. J Ovarian Res. 2011 Mar 30; 4(1):6. View in: Pubmed

      • C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin. Clin Cancer Res. 2011 Mar 01; 17(5):1065-74. View in: Pubmed

      • Treating gestational trophoblastic disease. Expert Opin Pharmacother. 2010 Dec; 11(18):3027-39. View in: Pubmed

      • Correlates of the preoperative level of CA125 at presentation of ovarian cancer. Gynecol Oncol. 2010 Dec; 119(3):462-8. View in: Pubmed

      • Gestational trophoblastic disease. Lancet. 2010 Aug 28; 376(9742):717-29. View in: Pubmed

      • Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol. 2010 Oct; 119(1):114-20. View in: Pubmed

      • Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. J Reprod Med. 2010 Jul-Aug; 55(7-8):279-84. View in: Pubmed

      • Utility of chromosomal chromogenic in situ hybridization as an alternative to flow cytometry and cytogenetics in the diagnosis of early partial hydatidiform moles: a validation study. J Reprod Med. 2010 Jul-Aug; 55(7-8):275-8. View in: Pubmed

      • 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2010 May-Jun; 55(5-6):253-7. View in: Pubmed

      • Complete hydatidiform mole in women older than age 50. J Reprod Med. 2010 May-Jun; 55(5-6):208-12. View in: Pubmed

      • Gestational trophoblastic disease. Presentations from the XVth World Congress on gestational trophoblastic diseases. J Reprod Med. 2010 May-Jun; 55(5-6):182-3. View in: Pubmed

      • The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2010 May-Jun; 55(5-6):194-8. View in: Pubmed

      • Age related cellular immune response against complete molar pregnancy. J Reprod Med. 2010 May-Jun; 55(5-6):261-6. View in: Pubmed

      • "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases". Gynecol Oncol. 2010 Jun; 117(3):505-6; author reply 506-7. View in: Pubmed

      • The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. J Pathol. 2010 Jan; 220(1):17-23. View in: Pubmed

      • Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. Eur J Cancer. 2010 Jan; 46(1):170-9. View in: Pubmed

      • A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 2009 Dec 08; 16(6):521-32. View in: Pubmed

      • The epidemiology of ovarian granulosa cell tumors: a case-control study. Gynecol Oncol. 2009 Nov; 115(2):221-5. View in: Pubmed

      • Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia. 2009 Jun; 11(6):529-41. View in: Pubmed

      • Clinical practice. Molar pregnancy. N Engl J Med. 2009 Apr 16; 360(16):1639-45. View in: Pubmed

      • Management of gestational trophoblastic neoplasia. Semin Oncol. 2009 Apr; 36(2):181-9. View in: Pubmed

      • Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2009 Feb; 112(2):353-7. View in: Pubmed

      • Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7667-73. View in: Pubmed

      • RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol. 2009 Feb; 112(2):325-30. View in: Pubmed

      • Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol. 2008 Dec; 111(3):425-30. View in: Pubmed

      • Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009 Mar; 112(3):654-62. View in: Pubmed

      • Vascularization and expression of angiogenic factors in partial and complete molar pregnancies. J Reprod Med. 2008 Aug; 53(8):589-94. View in: Pubmed

      • Immune cell profiling in intraplacental and postmolar choriocarcinomas. J Reprod Med. 2008 Aug; 53(8):558-64. View in: Pubmed

      • Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008 Jul; 53(7):481-6. View in: Pubmed

      • The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2008 Jul; 53(7):493-8. View in: Pubmed

      • Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy. J Reprod Med. 2008 Jul; 53(7):528-34. View in: Pubmed

      • Diagnosis and treatment of high-risk metastatic gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2008 Jul; 53(7):541-6. View in: Pubmed

      • Gestational trophoblastic disease: presentations from the XLVTH World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2008 Jul; 53(7):455-6. View in: Pubmed

      • Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Int J Gynecol Pathol. 2008 Apr; 27(2):247-51. View in: Pubmed

      • Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease. Int J Gynecol Pathol. 2008 Apr; 27(2):292-6. View in: Pubmed

      • Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms. Gynecol Oncol. 2008 May; 109(2):234-9. View in: Pubmed

      • Classification of ovarian cancer: a genomic analysis. Adv Exp Med Biol. 2008; 622:23-33. View in: Pubmed

      • Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):976-84. View in: Pubmed

      • Overexpression of laminin receptor 1 on decidual cells in partial and complete mole. Gynecol Oncol. 2008 Jan; 108(1):121-5. View in: Pubmed

      • Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 Oct; 16(10):895-903. View in: Pubmed

      • Immune cell profiling in normal pregnancy, partial and complete molar pregnancy. Gynecol Oncol. 2007 Nov; 107(2):292-7. View in: Pubmed

      • Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007 Sep 01; 25(25):3985-90. View in: Pubmed

      • Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc. Obstet Gynecol. 2007 Aug; 110(2 Pt 2):498-501. View in: Pubmed

      • Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. J Clin Oncol. 2007 Jun 01; 25(16):2281-7. View in: Pubmed

      • Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 2007 Aug; 106(2):311-7. View in: Pubmed

      • Erratum: Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007 May 24; 16(10). View in: Pubmed

      • Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report. J Reprod Med. 2007 May; 52(5):431-4. View in: Pubmed

      • Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. Neoplasia. 2007 Apr; 9(4):304-14. View in: Pubmed

      • Gestational trophoblastic disease. Clin Obstet Gynecol. 2007 Mar; 50(1):112-22. View in: Pubmed

      • Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 2007 Feb; 31(2):161-9. View in: Pubmed

      • An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol. 2007 Mar; 103(3-5):642-4. View in: Pubmed

      • Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers. 2007; 23(5-6):367-76. View in: Pubmed

      • Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med. 2006 Nov; 51(11):902-6. View in: Pubmed

      • Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. J Reprod Med. 2006 Nov; 51(11):871-4. View in: Pubmed

      • 25 years' experience in the treatment of gestational trophoblastic neoplasia in Hungary. J Reprod Med. 2006 Oct; 51(10):841-8. View in: Pubmed

      • Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs. Hum Pathol. 2007 Jan; 38(1):134-9. View in: Pubmed

      • Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol. 2006 Aug; 108(2):393-6. View in: Pubmed

      • Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol. 2006 Nov; 103(2):570-4. View in: Pubmed

      • Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1501-7. View in: Pubmed

      • Selenium binding protein 1 in ovarian cancer. Int J Cancer. 2006 May 15; 118(10):2433-40. View in: Pubmed

      • Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol. 2006 Aug; 102(2):160-4. View in: Pubmed

      • Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia. 2006 Apr; 8(4):268-78. View in: Pubmed

      • Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2006 Mar; 107(3):743. View in: Pubmed

      • Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 1):690-700. View in: Pubmed

      • Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006 Jan 15; 12(2):432-41. View in: Pubmed

      • Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer. Med Oncol. 2006; 23(2):205-12. View in: Pubmed

      • PTEN expression in clear cell adenocarcinoma of the ovary. Gynecol Oncol. 2006 Apr; 101(1):71-5. View in: Pubmed

      • Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Clin Cancer Res. 2005 Nov 01; 11(21):7651-7. View in: Pubmed

      • Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6880-8. View in: Pubmed

      • The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol. 2005 Oct; 99(1):3-5. View in: Pubmed

      • Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol. 2005 Sep; 106(3):548-52. View in: Pubmed

      • Ovarian cancer is a heterogeneous disease. Cancer Genet Cytogenet. 2005 Sep; 161(2):170-3. View in: Pubmed

      • Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005 May; 97(2):310-7. View in: Pubmed

      • Conditions associated with antibodies against the tumor-associated antigen MUC1 and their relationship to risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1125-31. View in: Pubmed

      • Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; (34):94-8. View in: Pubmed

      • Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol Oncol. 2005 Jan; 96(1):77-83. View in: Pubmed

      • A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer. Gynecol Oncol. 2005 Jan; 96(1):198-203. View in: Pubmed

      • Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform. Cancer Genet Cytogenet. 2004 Dec; 155(2):97-107. View in: Pubmed

      • The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol. 2004 Dec; 95(3):421-2. View in: Pubmed

      • Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Obstet Gynecol. 2004 Sep; 104(3):551-4. View in: Pubmed

      • Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer. 2004 Aug 16; 91(4):725-31. View in: Pubmed

      • Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med. 2004 Aug; 49(8):630-6. View in: Pubmed

      • Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med. 2004 Aug; 49(8):589-94. View in: Pubmed

      • Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies. Gynecol Oncol. 2004 Jun; 93(3):702-7. View in: Pubmed

      • Molecular biology of gestational trophoblastic neoplasia: a review. J Reprod Med. 2004 Jun; 49(6):415-22. View in: Pubmed

      • Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med. 2004 Jun; 49(6):411-4. View in: Pubmed

      • Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res. 2004 May 15; 10(10):3474-8. View in: Pubmed

      • Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology. 2004; 67(3-4):291-9. View in: Pubmed

      • Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 Dec; 17(6):959-68. View in: Pubmed

      • A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies. Gynecol Oncol. 2003 Nov; 91(2):293-8. View in: Pubmed

      • Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer. Clin Cancer Res. 2003 Oct 15; 9(13):4782-91. View in: Pubmed

      • Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors. Gynecol Oncol. 2003 Sep; 90(3):610-8. View in: Pubmed

      • Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma. Int J Clin Pract. 2003 Sep; 57(7):567-72. View in: Pubmed

      • Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res. 2003 Aug 01; 9(8):2904-11. View in: Pubmed

      • Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol. 2003 Apr; 101(4):732-6. View in: Pubmed

      • Osteopontin is down-regulated in hydatidiform mole. Gynecol Oncol. 2003 Apr; 89(1):134-9. View in: Pubmed

      • Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol. 2003 Mar; 88(3):424-8. View in: Pubmed

      • Successful term pregnancy after selective arterial embolization of symptomatic arteriovenous malformation in the setting of gestational trophoblastic tumor. Gynecol Oncol. 2003 Jan; 88(1):69-72. View in: Pubmed

      • Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002 Aug; 1(10):769-76. View in: Pubmed

      • Human papillomaviruses. Applications, caveats and prevention. J Reprod Med. 2002 Jul; 47(7):519-28; discussion 528-9. View in: Pubmed

      • Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer. Cancer Res. 2002 Jun 01; 62(11):3058-62. View in: Pubmed

      • Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. J Reprod Med. 2002 May; 47(5):355-62. View in: Pubmed

      • Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 2002 May; 47(5):380-6. View in: Pubmed

      • Quality of life after gestational trophoblastic disease. J Reprod Med. 2002 May; 47(5):387-94. View in: Pubmed

      • Recent advances in molecular biology of gestational trophoblastic diseases. A review. J Reprod Med. 2002 May; 47(5):369-79. View in: Pubmed

      • Advances in the understanding of placental site trophoblastic tumor. J Reprod Med. 2002 May; 47(5):337-41. View in: Pubmed

      • Recent advances in the management of gestational trophoblastic disease: a symposium. J Reprod Med. 2002 May; 47(5):335-6. View in: Pubmed

      • Do nontriploid partial hydatidiform moles exist? A histologic and flow cytometric reevaluation of nontriploid specimens. J Reprod Med. 2002 May; 47(5):363-8. View in: Pubmed

      • Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 2002 Apr 03; 287(13):1671-9. View in: Pubmed

      • Advances in the management of endometrial adenocarcinoma. A review. J Reprod Med. 2002 Mar; 47(3):173-89; discussion 189-90. View in: Pubmed

      • Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001 Oct 03; 93(19):1458-64. View in: Pubmed

      • Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res. 2001 Oct 01; 61(19):7264-7. View in: Pubmed

      • Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol. 2001 Sep; 82(3):415-9. View in: Pubmed

      • A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors. Cancer. 2001 Sep 01; 92(5):1156-67. View in: Pubmed

      • SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol. 2001 Aug; 159(2):609-22. View in: Pubmed

      • k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol. 2001 Jul; 20(3):244-51. View in: Pubmed

      • Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 2001 May 15; 61(10):4169-74. View in: Pubmed

      • The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol Oncol. 2001 May; 81(2):206-12. View in: Pubmed

      • Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol. 2000 Dec; 27(6):678-85. View in: Pubmed

      • Recent advances in gestational trophoblastic disease. J Reprod Med. 2000 Sep; 45(9):692-700. View in: Pubmed

      • Recent advances in the understanding of reproductive malignancies. A new section. J Reprod Med. 2000 Sep; 45(9):691. View in: Pubmed

      • Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol. 2000 Aug; 16(2):188-91. View in: Pubmed

      • Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol. 2000 Jul; 18(14):2728-32. View in: Pubmed

      • Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum. Am J Clin Pathol. 2000 Jul; 114(1):93-9. View in: Pubmed

      • Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol. 2000 Jun; 77(3):369-76. View in: Pubmed

      • Gestational trophoblastic disease. Curr Treat Options Oncol. 2000 Jun; 1(2):169-75. View in: Pubmed

      • Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol (1985). 2000 Jun; 88(6):2138-42. View in: Pubmed

      • Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol. 2000 Jun; 77(3):389-93. View in: Pubmed

      • Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Gynecol Oncol. 2000 May; 77(2):271-7. View in: Pubmed

      • Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene. 2000 Apr 06; 19(15):1885-90. View in: Pubmed

      • ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Apr; 77(1):105-11. View in: Pubmed

      • BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res. 2000 Mar 01; 60(5):1361-4. View in: Pubmed

      • Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum. Gynecol Oncol. 2000 Mar; 76(3):369-72. View in: Pubmed

      • Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol. 2000 Mar; 31(3):367-73. View in: Pubmed

      • CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. J Reprod Med. 2000 Feb; 45(2):94-6. View in: Pubmed

      • Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol. 2000 Feb; 156(2):409-17. View in: Pubmed

      • Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol Oncol. 1999 Dec; 75(3):391-6. View in: Pubmed

      • Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol. 1999 Nov; 75(2):248-53. View in: Pubmed

      • Repetitive hydatidiform mole with different male partners. Gynecol Oncol. 1999 Nov; 75(2):224-6. View in: Pubmed

      • Outcome of pregnancies occurring within 1 year of hydatidiform mole. Obstet Gynecol. 1999 Oct; 94(4):588-90. View in: Pubmed

      • Trophoblastic pulmonary embolization after hysterectomy for invasive complete mole. A case report. J Reprod Med. 1999 Oct; 44(10):908-12. View in: Pubmed

      • Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. Gynecol Oncol. 1999 Jun; 73(3):345-7. View in: Pubmed

      • Bulky, barrel-shaped cervical carcinoma (stages IB, IIA, IIB): the prognostic factors for pelvic control and treatment outcome. Am J Clin Oncol. 1999 Jun; 22(3):232-6. View in: Pubmed

      • Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst. 1999 Apr 07; 91(7):635-40. View in: Pubmed

      • A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res. 1999 Feb 15; 27(4):993-1000. View in: Pubmed

      • Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors. Oncogene. 1999 Jan 07; 18(1):257-62. View in: Pubmed

      • BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol. 1998 Oct; 92(4 Pt 1):596-600. View in: Pubmed

      • Predicting risk of complications with gynecologic laparoscopic surgery. Obstet Gynecol. 1998 Sep; 92(3):327-31. View in: Pubmed

      • DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene. 1998 Jul 30; 17(4):419-24. View in: Pubmed

      • Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum. Oncogene. 1998 Jul 02; 16(26):3455-9. View in: Pubmed

      • Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst. 1998 Jun 03; 90(11):841-5. View in: Pubmed

      • Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998 Jun 01; 58(11):2328-30. View in: Pubmed

      • DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 1998 May 07; 16(18):2381-7. View in: Pubmed

      • p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):119-27. View in: Pubmed

      • A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer. 1998 Feb 01; 82(3):561-6. View in: Pubmed

      • Recent advances in gestational trophoblastic disease. Curr Opin Obstet Gynecol. 1998 Feb; 10(1):61-4. View in: Pubmed

      • c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med. 1998 Feb; 43(2):101-10. View in: Pubmed

      • A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Oncogene. 1998 Jan 29; 16(4):555-9. View in: Pubmed

      • A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumors. Oncogene. 1998 Jan 15; 16(2):197-202. View in: Pubmed

      • Natural history of postterm choriocarcinoma. J Reprod Med. 1998 Jan; 43(1):75-80. View in: Pubmed

      • Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J Reprod Med. 1998 Jan; 43(1):37-43. View in: Pubmed

      • Complete molar pregnancy. Clinical trends at King Fahad Hospital, Riyadh, Kingdom of Saudi Arabia. J Reprod Med. 1998 Jan; 43(1):11-3. View in: Pubmed

      • Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med. 1998 Jan; 43(1):21-7. View in: Pubmed

      • Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 1998 Jan; 43(1):81-6. View in: Pubmed

      • Reproductive outcome after methotrexate treatment of tubal pregnancies. J Reprod Med. 1998 Jan; 43(1):28-32. View in: Pubmed

      • Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene. 1997 Jun 19; 14(24):2979-84. View in: Pubmed

      • Enhancement of 131I-mediated cytotoxicity by caffeine. Gynecol Oncol. 1997 May; 65(2):253-7. View in: Pubmed

      • A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. Cancer Res. 1997 Feb 01; 57(3):387-90. View in: Pubmed

      • The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. Gynecol Oncol. 1997 Jan; 64(1):156-9. View in: Pubmed

      • The diagnosis of molar pregnancy by ultrasound: a continuing challenge. Ultrasound Obstet Gynecol. 1997 Jan; 9(1):4-5. View in: Pubmed

      • Chorionic tumors. N Engl J Med. 1996 Dec 05; 335(23):1740-8. View in: Pubmed

      • d-fenfluramine treatment of binge eating disorder. Am J Psychiatry. 1996 Nov; 153(11):1455-9. View in: Pubmed

      • Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 1996 Jun 01; 56(11):2501-5. View in: Pubmed

      • Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Oncogene. 1996 May 16; 12(10):2147-53. View in: Pubmed

      • SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 1996 May 02; 12(9):1895-901. View in: Pubmed

      • Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. Am J Clin Pathol. 1996 Apr; 105(4):411-6. View in: Pubmed

      • Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res. 1996 Mar 15; 56(6):1250-2. View in: Pubmed

      • A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene. 1996 Feb 15; 12(4):735-40. View in: Pubmed

      • Gestational trophoblastic disease. Cancer. 1995 Nov 15; 76(10 Suppl):2079-85. View in: Pubmed

      • The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995 Nov; 86(5):775-9. View in: Pubmed

      • Twin pregnancies with complete hydatidiform mole and coexisting fetus: use of fluorescent in situ hybridization to evaluate placental X- and Y-chromosomal content. Hum Pathol. 1995 Nov; 26(11):1175-80. View in: Pubmed

      • Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene. 1995 Oct 05; 11(7):1249-54. View in: Pubmed

      • Case-control study of risk factors for partial molar pregnancy. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):788-94. View in: Pubmed

      • Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma. Obstet Gynecol. 1995 Sep; 86(3):379-85. View in: Pubmed

      • Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol. 1995 Jun; 57(3):299-303. View in: Pubmed

      • Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res. 1995 Jun; 218(2):499-507. View in: Pubmed

      • Detailed deletion mapping of chromosome 6q in borderline epithelial ovarian tumors. Cancer Res. 1995 May 15; 55(10):2169-72. View in: Pubmed

      • Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol. 1995 Apr; 22(2):157-60. View in: Pubmed

      • Low-risk metastatic gestational trophoblastic tumors. Semin Oncol. 1995 Apr; 22(2):166-71. View in: Pubmed

      • Predicting endometrial cancer among older women who present with abnormal vaginal bleeding. Gynecol Oncol. 1995 Mar; 56(3):376-81. View in: Pubmed

      • Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res. 1995 Feb 01; 55(3):490-2. View in: Pubmed

      • Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994 Dec; 55(12):517-22. View in: Pubmed

      • p53 gene mutation in human borderline epithelial ovarian tumors. J Natl Cancer Inst. 1994 Oct 19; 86(20):1549-51. View in: Pubmed

      • Two-year follow-up of 263 patients with post/perimenopausal vaginal bleeding and negative initial biopsy. Gynecol Oncol. 1994 Oct; 55(1):56-9. View in: Pubmed

      • In vitro regulation of stromelysin-1 in human endometrial stromal cells. Ann N Y Acad Sci. 1994 Sep 06; 732:479-81. View in: Pubmed

      • Somatization in patients with dissociative disorders. Am J Psychiatry. 1994 Sep; 151(9):1329-34. View in: Pubmed

      • Pseudomyxoma peritonei: a review of 23 cases. Obstet Gynecol. 1994 Jul; 84(1):17-21. View in: Pubmed

      • Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):545-8. View in: Pubmed

      • Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Gynecol Oncol. 1994 Apr; 53(1):78-83. View in: Pubmed

      • Brain metastases of gestational trophoblastic tumor. J Reprod Med. 1994 Mar; 39(3):179-84. View in: Pubmed

      • Cytokine regulation of trophoblast steroidogenesis. J Clin Endocrinol Metab. 1994 Mar; 78(3):586-91. View in: Pubmed

      • Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners. J Reprod Med. 1994 Mar; 39(3):163-7. View in: Pubmed

      • Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. J Reprod Med. 1994 Mar; 39(3):147-54. View in: Pubmed

      • Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992. J Reprod Med. 1994 Mar; 39(3):228-32. View in: Pubmed

      • Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. J Reprod Med. 1994 Mar; 39(3):175-8. View in: Pubmed

      • Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro. J Reprod Med. 1994 Mar; 39(3):209-16. View in: Pubmed

      • Current management of complete and partial molar pregnancy. J Reprod Med. 1994 Mar; 39(3):139-46. View in: Pubmed

      • Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol. 1994 Feb; 52(2):247-52. View in: Pubmed

      • Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus. Obstet Gynecol. 1994 Jan; 83(1):35-42. View in: Pubmed

      • The effects of cytokines on human chorionic gonadotropin (hCG) production by a trophoblast cell line. J Reprod Immunol. 1993 Dec; 25(3):235-47. View in: Pubmed

      • Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. Gynecol Oncol. 1993 Oct; 51(1):12-20. View in: Pubmed

      • Dissociative disorders in psychiatric inpatients. Am J Psychiatry. 1993 Jul; 150(7):1037-42. View in: Pubmed

      • Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obstet Gynecol. 1993 Jun; 81(6):968-75. View in: Pubmed

      • Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol. 1993 May; 168(5):1547-51. View in: Pubmed

      • CA125 measurement in epithelial ovarian cancer: a 10-year anniversary of clinical investigation. Gynecol Oncol. 1993 Apr; 49(1):1-2. View in: Pubmed

      • Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993 Apr 01; 53(7):1489-92. View in: Pubmed

      • Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol. 1993 Jan; 48(1):5-10. View in: Pubmed

      • Molar villous fluid suppresses mononuclear cell cytotoxicity. Gynecol Oncol. 1992 Dec; 47(3):311-6. View in: Pubmed

      • The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol. 1992 Sep; 46(3):367-71. View in: Pubmed

      • Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol. 1992 Aug; 46(2):226-9. View in: Pubmed

      • Interferon-gamma receptors on human gestational choriocarcinoma cell lines: quantitative and functional studies. Am J Obstet Gynecol. 1992 Aug; 167(2):524-30. View in: Pubmed

      • Gestational trophoblastic diseases: recent advances in the understanding of cytogenetics, histopathology, and natural history. Curr Opin Obstet Gynecol. 1992 Aug; 4(4):616-20. View in: Pubmed

      • The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol. 1992 Jul; 46(1):74-81. View in: Pubmed

      • A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol. 1992 Mar; 79(3):403-10. View in: Pubmed

      • Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Res. 1991 Nov-Dec; 11(6):1975-82. View in: Pubmed

      • A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstet Gynecol. 1991 Sep; 78(3 Pt 1):402-9. View in: Pubmed

      • Pathologic features of sharp curettings in complete hydatidiform mole. Predictors of persistent gestational trophoblastic disease. J Reprod Med. 1991 Jan; 36(1):17-20. View in: Pubmed

      • Gestational trophoblastic disease of the fallopian tube. J Reprod Med. 1991 Jan; 36(1):57-60. View in: Pubmed

      • Management of low-risk metastatic gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):36-9. View in: Pubmed

      • Evolving concepts of molar pregnancy. J Reprod Med. 1991 Jan; 36(1):40-4. View in: Pubmed

      • Duplex ultrasonography for persistent gestational trophoblastic tumor. J Reprod Med. 1991 Jan; 36(1):14-6. View in: Pubmed

      • Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol. 1991 Jan; 77(1):111-5. View in: Pubmed

      • Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1991 Jan; 36(1):3-8. View in: Pubmed

      • Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol. 1990 Nov; 39(2):195-8. View in: Pubmed

      • A trial of family therapy versus a relatives' group for schizophrenia. Two-year follow-up. Br J Psychiatry. 1990 Oct; 157:571-7. View in: Pubmed

      • Recent advances in the biology and treatment of gestational trophoblastic diseases and germ cell tumors. Curr Opin Oncol. 1990 Oct; 2(5):901-5. View in: Pubmed

      • Localization of leukocytes and cytokines in chorionic villi of normal placentas and complete hydatidiform moles. Gynecol Oncol. 1990 Jun; 37(3):396-400. View in: Pubmed

      • Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990 Mar; 36(3):358-62. View in: Pubmed

      • Multifetal gestation. Clin Obstet Gynecol. 1990 Mar; 33(1):79-87. View in: Pubmed

      • Hepatic scintigraphic changes associated with gestational trophoblastic disease. Eur J Nucl Med. 1990; 16(8-10):721-3. View in: Pubmed

      • Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol. 1990 Jan; 36(1):56-9. View in: Pubmed

      • Gestational trophoblastic tumors and malignant ovarian germ cell tumors. Curr Opin Oncol. 1989 Oct; 1(1):119-22. View in: Pubmed

      • Gestational trophoblastic diseases. Semin Oncol. 1989 Oct; 16(5):410-6. View in: Pubmed

      • Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol. 1989 Aug; 74(2):212-6. View in: Pubmed

      • Repetitive complete and partial hydatidiform mole. Obstet Gynecol. 1989 Aug; 74(2):217-9. View in: Pubmed

      • Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989 Mar; 73(3 Pt 1):414-8. View in: Pubmed

      • Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med. 1989 Mar; 34(3):189-92. View in: Pubmed

      • A trial of family therapy v. a relatives group for schizophrenia. Br J Psychiatry. 1989 Jan; 154:58-66. View in: Pubmed

      • Diagnosis and management of the primary hydatidiform mole. Obstet Gynecol Clin North Am. 1988 Sep; 15(3):491-503. View in: Pubmed

      • Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem. 1988 Jul 05; 263(19):9402-8. View in: Pubmed

      • Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center. Obstet Gynecol. 1988 Jun; 71(6 Pt 1):854-7. View in: Pubmed

      • Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. Gynecol Oncol. 1988 Feb; 29(2):199-207. View in: Pubmed

      • Cross-reactivity of monoclonal antibodies directed against lymphocyte markers with trophoblast cells of normal placenta, hydatidiform mole, and gestational choriocarcinoma. Gynecol Oncol. 1988 Jan; 29(1):94-100. View in: Pubmed

      • Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol. 1988 Jan; 158(1):193-8. View in: Pubmed

      • Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro. Am J Obstet Gynecol. 1988 Jan; 158(1):199-203. View in: Pubmed

      • Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1987 Sep; 32(9):680-4. View in: Pubmed

      • Management of complete molar pregnancy. J Reprod Med. 1987 Sep; 32(9):634-9. View in: Pubmed

      • Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol. 1987 Mar; 69(3 Pt 1):390-5. View in: Pubmed

      • Persistence of partial mole. Am J Clin Pathol. 1987 Mar; 87(3):377-80. View in: Pubmed

      • Expression of trophoblast-leukocyte common antigens and placental-type alkaline phosphatase in complete molar pregnancy. Am J Obstet Gynecol. 1986 Aug; 155(2):443-6. View in: Pubmed

      • Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med. 1986 Mar; 31(3):179-83. View in: Pubmed

      • Immunobiology of complete molar pregnancy and gestational trophoblastic tumor. Cancer Metastasis Rev. 1986; 5(2):109-23. View in: Pubmed

      • Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol. 1986 Jan; 23(1):111-8. View in: Pubmed

      • Natural history of partial molar pregnancy. Obstet Gynecol. 1985 Nov; 66(5):677-81. View in: Pubmed

      • Reactivity of anti-human sperm monoclonal antibodies with normal placenta, hydatidiform mole, and gestational choriocarcinoma. Gynecol Oncol. 1985 Nov; 22(3):334-40. View in: Pubmed

      • Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar. J Immunol. 1985 Oct; 135(4):2498-501. View in: Pubmed

      • Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1016-20. View in: Pubmed

      • Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1003-10. View in: Pubmed

      • A controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry. 1985 Jun; 146:594-600. View in: Pubmed

      • Implantation site in complete molar pregnancy: a study of immunologically competent cells with monoclonal antibodies. Am J Obstet Gynecol. 1985 May 01; 152(1):97-9. View in: Pubmed

      • The issue of microinvasive squamous cell carcinoma of the vulva: an evaluation of the criteria of diagnosis and methods of therapy. Obstet Gynecol Surv. 1985 Mar; 40(3):136-43. View in: Pubmed

      • Sonographically monitored amniocentesis to decrease intraoperative complications. Obstet Gynecol. 1985 Mar; 65(3):426-30. View in: Pubmed

      • Localization of stage-specific embryonic antigens in hydatidiform mole, normal placenta, and gestational choriocarcinoma. Gynecol Oncol. 1985 Jan; 20(1):71-7. View in: Pubmed

      • Localization of transferrin receptor in the chorionic villi of complete molar pregnancy. Am J Obstet Gynecol. 1985 Jan 01; 151(1):128-9. View in: Pubmed

      • Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Am J Obstet Gynecol. 1984 Nov 15; 150(6):723-8. View in: Pubmed

      • Immunobiology of molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1984 Nov; 29(11):796-801. View in: Pubmed

      • Staging system for gestational trophoblastic tumors. J Reprod Med. 1984 Nov; 29(11):792-5. View in: Pubmed

      • Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. Gynecol Oncol. 1984 Oct; 19(2):173-81. View in: Pubmed

      • Histocompatibility antigens (HLA-A,B,C) are not detectable in molar villous fluid. Gynecol Oncol. 1984 Sep; 19(1):74-8. View in: Pubmed

      • Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia. J Natl Cancer Inst. 1984 May; 72(5):983-90. View in: Pubmed

      • Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom. J Clin Psychiatry. 1984 May; 45(5 Pt 2):43-9. View in: Pubmed

      • Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia. Cancer. 1984 Mar 15; 53(6):1316-21. View in: Pubmed

      • Reproductive performance after molar pregnancy and gestational trophoblastic tumors. Clin Obstet Gynecol. 1984 Mar; 27(1):221-7. View in: Pubmed

      • Choriocarcinoma following term gestation. Gynecol Oncol. 1984 Jan; 17(1):52-7. View in: Pubmed

      • The role of regional centers for gestational trophoblastic disease. Adv Exp Med Biol. 1984; 176:383-400. View in: Pubmed

      • A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13; 309(15):883-7. View in: Pubmed

      • Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line. Am J Obstet Gynecol. 1983 Jul 15; 146(6):607-12. View in: Pubmed

      • Pelvic ultrasonography and the management of gestational trophoblastic disease. Gynecol Oncol. 1983 Jun; 15(3):403-12. View in: Pubmed

      • Distribution of major histocompatibility (HLA) antigens in chorionic villi of molar pregnancy. Am J Obstet Gynecol. 1983 May 15; 146(2):221-2. View in: Pubmed

      • Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum. Cancer Res. 1983 Mar; 43(3):1395-401. View in: Pubmed

      • Circulating immune complex levels in patients with molar pregnancy. Obstet Gynecol. 1983 Feb; 61(2):165-8. View in: Pubmed

      • Immunopathologic study of the implantation site in molar pregnancy. Am J Obstet Gynecol. 1982 Dec 15; 144(8):925-30. View in: Pubmed

      • Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease. Cancer. 1982 Nov 15; 50(10):2024-7. View in: Pubmed

      • 45,X complete hydatidiform mole. Gynecol Oncol. 1982 Oct; 14(2):279-83. View in: Pubmed

      • A controlled trial of social intervention in the families of schizophrenic patients. Br J Psychiatry. 1982 Aug; 141:121-34. View in: Pubmed

      • Circulating immune complex levels in patients with gestational trophoblastic neoplasia. J Natl Cancer Inst. 1982 Jul; 69(1):23-6. View in: Pubmed

      • Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms. Semin Oncol. 1982 Jun; 9(2):191-7. View in: Pubmed

      • Gestational trophoblastic neoplasms. Clinical principles of diagnosis and management. Major Probl Obstet Gynecol. 1982; 14:1-301. View in: Pubmed

      • Measurement of human chorionic gonadotropin. Major Probl Obstet Gynecol. 1982; 14:64-97. View in: Pubmed

      • Cerebrospinal fluid human chorionic gonadotropin levels in normal pregnancy and choriocarcinoma. Surg Gynecol Obstet. 1981 Nov; 153(5):687-9. View in: Pubmed

      • Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol. 1981 Oct; 58(4):474-7. View in: Pubmed

      • Estrogen production as a tumor marker in patients with gonadotropin-producing neoplasms. Cancer Res. 1981 Apr; 41(4):1447-50. View in: Pubmed

      • Management of molar pregnancy. J Reprod Med. 1981 Apr; 26(4):208-12. View in: Pubmed

      • Management of nonmetastatic trophoblastic tumors. J Reprod Med. 1981 Apr; 26(4):219-22. View in: Pubmed

      • Horizons in the management of gestational trophoblastic neoplasia: analysis of treatment failure. J Reprod Med. 1981 Apr; 26(4):227-9. View in: Pubmed

      • Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu. 1981; 11:391-411. View in: Pubmed

      • HL-A antigen frequency distribution in patients with gestational choriocarcinoma and their husbands. Placenta Suppl. 1981; 3:263-7. View in: Pubmed

      • Oral contraceptives and post-molar trophoblastic tumours. Lancet. 1980 Oct 04; 2(8197):752. View in: Pubmed

      • Pretreatment curettage-A predictor of chemotherapy response in gestational trophoblastic neoplasia. Gynecol Oncol. 1980 Aug; 10(1):39-43. View in: Pubmed

      • Psychological and social impact of gestational trophoblastic neoplasia. J Reprod Med. 1980 Jul; 25(1):14-6. View in: Pubmed

      • Laparoscopy in the management of gestational trophoblastic neoplasms. J Reprod Med. 1980 Jun; 24(6):261-4. View in: Pubmed

      • Embolization of pelvic arteries for control of postpartum hemorrhage. Obstet Gynecol. 1980 Jun; 55(6):754-8. View in: Pubmed

      • Natural history of recurrent molar pregnancy. Obstet Gynecol. 1980 Apr; 55(4):457-9. View in: Pubmed

      • Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms. Cancer. 1980 Feb; 45(3):423-6. View in: Pubmed

      • Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms. Obstet Gynecol. 1979 Dec; 54(6):725-8. View in: Pubmed

      • Invasive cervical carcinoma in young women. Gynecol Oncol. 1979 Dec; 8(3):311-6. View in: Pubmed

      • Proliferative sequelae after evacuation of partial hydatidiform mole. Lancet. 1979 Oct 13; 2(8146):804-5. View in: Pubmed

      • Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979 Apr; 48(4):633-8. View in: Pubmed

      • Natural history of partial hydatidiform moles. Lancet. 1979 Mar 31; 1(8118):719. View in: Pubmed

      • Ultrasound-directed percutaneous aspiration biopsy of periaortic lymph nodes in recurrence of cervical carcinoma. Am J Obstet Gynecol. 1978 Aug 15; 131(8):906-8. View in: Pubmed

      • Central nervous system involvement by ovarian carcinoma: a complication of prolonged survivial with metastatic disease. Cancer. 1978 Feb; 41(2):776-83. View in: Pubmed

      • Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol. 1978 Jan; 51(1 Suppl):34s-37s. View in: Pubmed

      • Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model. Am J Obstet Gynecol. 1977 Aug 01; 128(7):782-6. View in: Pubmed

      Locations

      Location Avtar

      Brigham and Women's Hospital

      75 Francis Street Boston, MA 02115
      Get Directions
      Location Avtar

      Dana-Farber Cancer Institute - Chestnut Hill

      300 Boylston Street Newton, MA 02459
      Get Directions
      Location Avtar

      Brigham and Women's Hospital

      75 Francis Street Boston, MA 02215
      Get Directions
      Location Avtar

      Dana-Farber Cancer Institute - Chestnut Hill

      300 Boylston Street Newton, MA 02459
      Get Directions

      Brigham and Women's Hospital

      Location Avtar

      Brigham and Women's Hospital

      75 Francis Street Boston, MA 02115
      Get Direction
      42.3362, -71.1067

      Dana-Farber Cancer Institute - Chestnut Hill

      Location Avtar

      Dana-Farber Cancer Institute - Chestnut Hill

      300 Boylston Street Newton, MA 02459
      Get Direction
      42.3192, -71.1798

      Brigham and Women's Hospital

      Location Avtar

      Brigham and Women's Hospital

      75 Francis Street Boston, MA 02215
      Get Direction
      42.3362, -71.1067

      Dana-Farber Cancer Institute - Chestnut Hill

      Location Avtar

      Dana-Farber Cancer Institute - Chestnut Hill

      300 Boylston Street Newton, MA 02459
      Get Direction
      42.3192, -71.1798

      Ratings and Comments

      Ross S. Berkowitz, MD

      About Our Ratings

      Physician Star Rating Comment Block

      Discovery and Insights